Topic: Israel

com), a developer of oral drug delivery systems, announced today that its work entitled "Extended exposure to an oral insulin formulation yields decreased insulin secretion in Type II diabetes subjects," will be presented at the Tenth Annual Meeting of the Diabetes Technology ...
High levels of triglycerides during pregnancy may be associated with an increased risk of developing gestational diabetes mellitus or preeclampsia, according to a study in the November issue of the American Journal of Obstetrics & Gynecology.. Arnon Wiznitzer, M.D., of Ben-Gurion University ...
Fasting glucose changes during acute myocardial infarction hospitalizations may serve as better prognostic indicators than fasting glucose taken at baseline, according to an Israeli study in the Oct. 15 American Journal of Cardiology.. Doron Aronson, M.D., of the Rambam Medical Center in ...
High-glycemic carbohydrates may be linked to reduced flow-mediated dilation in overweight individuals, perhaps pointing to a connection between such foods and cardiovascular disease risk, according to research published in the June 16 issue of the Journal of the American College of Cardiology.. ...
Scientists have found a healthy use for tobacco after breeding genetically modified plants containing a medicine that could stop type 1 diabetes. However, Mario Pezzotti of the University of Verona, who led the tobacco study published in the journal BMC Biotechnology, believes ...

Be Cautious at Christmas

12/12/2008 Print E-mail Holiday decorations, including trees and lights, should be properly set up and maintained to keep your home merry and safe.. Be careful where you place lit candles. Keep them away from trees and other decorations. Many plants, including mistletoe, ...
The Study Suggests That the GLP-1 Analog Exenatide -4 When Combined With Oramed's Absorption Promoters is Absorbed Through the Gastrointestinal Tract and Retains its Biological Activity. The study suggested that exenatide-4 when combined with Oramed's absorption promoters significantly reduces glucose absorption and ...
//www.oramed.com), a developer of proprietary drug delivery systems, announced today that its poster entitled "Enteral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs," Oramed's exploratory study of enteral delivery of GLP-1 analog, exenatide-4, an incretin mimetic with antihyperglycemic actions on ...
//www.oramed.com), a developer of oral delivery systems, announced today successful results from the clinical trial of its oral insulin capsule, ORMD 0801. "We are pleased with the results from the Phase 2A trial as they showed that ORMD 0801 was effective and ...

New Devices Shine a Light on Blood Sugar Control

6/23/2007 Print E-mail Two new devices that use light to measure diabetics' blood sugar levels show promise, according to studies to be presented Saturday in Chicago at the annual meeting of the American Diabetes Association.. Dr. Robert Gabbay of the Penn State ...
Previous
  • 1
  • 2